Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS.
December 10, 2025
By: Charlie Sternberg
The Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s lab transformation program, meaning it will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale genomic research, demand planning, and lab operations.
The multi-year digital transformation project is led by the Sanger Institute’s Core Operations team. Core Operations provides a broad range of cellular and genomic workflows that underpin the Institute’s end-to-end research and data-generation processes.
One of the initial goals of the transformation is to give Core Operations and scientific teams a clearer view of work coming into the lab, how that work moves through complex pipelines, resources that are required at each step, and provide access to key scientific data generated throughout the processing pipelines to scientists. In addition to implementing a dominant LIMS to underpin the research conducted by the Sanger Institute, the transformation will focus on the workflows, data, and instruments used across the Cellular Platforms and Genomic Platforms teams and eventually extend across all research teams.
“Sapio Sciences is honored to work alongside the Wellcome Sanger Institute as they continue shaping the future of genomic science,” said Mike Hampton, Chief Commercial Officer at Sapio Sciences. “Sanger helped set the standard for large-scale genomics, and they have very clear expectations for their scientific enablement. With this project, we will work together to put Sapio LIMS at the center of their lab operations, cut out avoidable friction in day-to-day work, and give teams better visibility of the data, workflows and resources that drive their science.”
“Giving our scientists clear, reliable answers to ‘Where is my sample and where is my data?’ across complex, multi-team workflows is one of our biggest challenges,” said Simon Moore, COO at the Wellcome Sanger Institute. “To plan and deliver their research, our scientists need confidence that sample progress and critical data are always visible and accessible. By moving to Sapio LIMS as our core platform, we can improve how we track, manage and orchestrate work; align resources; and streamline workflows. Sapio gives our scientists modern, configurable tools that keep pace with the way we do science.”
Taken together, the program is intended to give the Sanger Institute a clearer view of data generation progress, demand, capacity and scientific work across its labs; remove avoidable complexity from daily operations; and support faster, more reliable delivery of genomic science.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !